¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"potential energy barrier"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • motor evoked potential
    ¿îµ¿À¯¹ßÀüÀ§
  • myotonic potential
    ±Ù(À°)±äÀåÀüÀ§
  • maximal diastolic potential
    ÃÖ´ëÀ̿ϱâÀüÀ§
  • membrane potential
    ¸·ÀüÀ§
  • near field potential
    ±ÙÁ¢ºÎÀ§ÀüÀ§
  • negative potential
    À½ÀüÀ§
  • nerve action potential
    ½Å°æÈ°µ¿ÀüÀ§
  • oscillatory potential
    Áøµ¿¼ÒÆÄÀüÀ§
  • overshooting potential
    Áö³ªÄ¡±âÀüÀ§
  • oxidation-reduction potential
    »êȭȯ¿øÀüÀ§
  • pacemaker potential
    ±æÀâÀÌÀüÀ§, ¹Úµ¿Á¶À²±âÀüÀ§
  • plate potential
    ÆÇÀüÀ§
  • plateau potential
    °í¿øÀüÀ§, Á¤Á¡Áö¼ÓÀüÀ§
  • polarizing potential
    ºÐ±ØÀüÀ§, Æí±¤ÀüÀ§
  • polyphasic action potential
    ´Ù»óȰµ¿ÀüÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • excitatory postsynaptic potential
    ÈïºÐ½Ã³À½ºÈÄÀüÀ§, ÈïºÐ¿¬Á¢ÈÄÀüÀ§
  • fibrillation potential
    Àܶ³¸²ÀüÀ§, ¼¼µ¿ÀüÀ§
  • generator potential
    ¹ß»ý±âÀü¾Ð, ±âµ¿ÀüÀ§
  • giant potential
    °Å´ëÀüÀ§
  • potential gradient
    ÀüÀ§±â¿ï±â, ÀüÀ§Â÷
  • inhibitory postsynaptic potential
    ¾ïÁ¦½Ã³ÀÈÄÀüÀ§, ¾ïÁ¦¿¬Á¢ÈÄÀüÀ§
  • junctional potential
    Á¢ÇÕºÎÀüÀ§
  • maximal diastolic potential
    ÃÖ´ëÀ̿ϱâÀüÀ§
  • membrane potential
    ¸·ÀüÀ§
  • miniature end plate potential
    ²¿¸¶Á¾¸»ÆÇÀü¾Ð, ¹Ì¼¼Á¾¸»ÆÇÀüÀ§
  • monophasic action potential
    ´Ü»óȰµ¿ÀüÀ§
  • motor evoked potential
    ¿îµ¿½Å°æÀ¯¹ßÀüÀ§
  • myotonic potential
    ±ÙÀ°±äÀåÀüÀ§
  • potential acuity meter
    ÀáÀç½Ã·ÂÃøÁ¤±â
  • near field potential
    ±ÙÁ¢ºÎÀ§È°µ¿ÀüÀ§
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • energy flux density
    ¿¡³ÊÁö¼Ó¹Ðµµ
  • energy imparted
    ºÎ¿©¿¡³ÊÁö
  • energy metabolic rate
    ¿¡³ÊÁö´ë»çÀ².
  • energy metabolism
    ¿¡³ÊÁö´ë»ç.
  • energy metabolism
    ¿¡³ÊÁö´ë»ç(ÓÛÞó)
  • energy of activation
    Ȱ¼ºÈ­¿¡³ÊÁö.
  • energy parasite
    ¿¡³ÊÁö±â»ýü
  • energy quantum
    ¿¡³ÊÁö¾çÀÚ.
  • energy radiance
    ¿¡³ÊÁö±¤Ã¼
  • energy resolution
    ¿¡³ÊÁöºÐÇØ(´É)
  • energy source
    ¿¡³ÊÁö¿ø(¡­ê«).
  • energy spectrum
    ¿¡³ÊÁöºÐ±¤
  • energy transfer
    ¿¡³ÊÁöÀü´Þ(îîÓ¹)
  • energy transfer coefficient
    ¿¡³ÊÁöÀüÀ̰è¼ö
  • energy-rich bond
    ºÎ¿¡³ÊÁö°áÇÕ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • osmotic potential
    »ïÅõ´É(ß¶÷âÒö)
  • oxidation potential
    »êÈ­ ÀüÀ§(ß«ûùï³êÈ)
  • oxidation-reduction potential
    »êȭȯ¿ø ÀüÀ§(ß«ûùü½êªï³êÈ)
  • phosphate potential
    Àλê ÀüÀ§(×òß«ï³êÈ)
  • phosphate transfer potential
    ÀλêÀüÀÌ ÀüÀ§(×òß«ï®ì¹ï³êÈ)
  • phosphorylation potential
    ÀλêÈ­ ÀüÀ§(×òß«ûùï³êÈ)
  • phosphoryl transfer potential
    ÀλêÈ­ ÀüÀÌ ÀüÀ§(×òß«ûùï®ì¹ï³êÈ)
  • potential
    "ÀüÀ§(ï³êÈ), Æ÷ÅÙ¼È"
  • potential difference
    ÀüÀ§Â÷(ï³êÈó¬)
  • potential-drop method
    ÀüÀ§ °­ÇϹý(ï³êÈ˽ù»Ûö)
  • potential gradient
    "ÀüÀ§ ±¸¹è(ï³êÈÎþÛÕ), ÆÛÅÙ¼È ±¸¹è(ÎþÛÕ)"
  • potential mediator
    "ÀüÀ§ ¸Å°³ÀÚ(ï³êÈØÚË¿íº), ÆÛÅÙ¼È ¸Å°³ÀÚ(ØÚË¿íº)"
  • potential well
    ÀüÀ§(ï³êÈ) ¿ì¹°
  • proton transfer potential
    ¾ç¼ºÀÚ(åÕàõí­) ÀüÀÌ ÀüÀ§(ï®ì¹ï³êÈ)
  • redox potential
    ·¹µ¶½º ÀüÀ§(ï³êÈ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
AEC ankyloblepharon, ectodermal defects, and cleft lip [syndrome]; at earliest convenience; Atomic Energ...
AEE atomic energy establishment
AERE Atomic Energy Research Establishment
AHES artificial heart energy system
APDER anterior-posterior dual energy radiography
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
DEXA Dual Energy X Ray Absorptiometry
DXA Dual Energy X-ray Absorptiometry
EELS Electron Energy Loss Spectroscopy
EDS Energy Dispersive Spectrometry
EDXA Energy Dispersive X-Ray Analysis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • rheobasic potential
    ±âÀü¾Ð
  • somatosensory evoked potential
    ü¼º °¨°¢ ¹ßÀüÀ§
  • synaptic potential
    ½Ã³³½º ÀüÀ§
  • threshold membrane potential
    ¹®Åθ·Àü, ¿ªÄ¡¸· ÀüÀ§
  • transmembrane potential difference
    ¸·ÀüÀ§ Â÷ÀÌ
  • zeta potential
    Á¦Å¸ Àü¾Ð
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
Gibbs energy of activation The Gibbs energy that must be added to that already possessed by a molecule or molecules in order to initiate a reaction.
(05 Mar 2000)
gibbs free energy The total amount of energy which is either used up or released during a chemical reaction. Gibbs free energy (delta G) = (delta H) - t (delta s): where (delta H) is the change in enthalpy, calculated by adding up the amount of energy released or used up to break or form chemical bonds during the reaction, t is the temperature at which the reaction took place, and (delta S) is the change in entropy, or amount of disorder, that occurs in the molecules involved during the reaction.
(09 Oct 1997)
renewable energy resource <ecology> An energy resource replenished continuously or that is replaced after use through natural means. Sustainable energy.
Renewable energy resources include bioenergy, solar energy, wind energy, geothermal power, and hydropower.
(25 Jun 1999)
resonance energy transfer <technique> Transfer of energy from one fluorochrome to another. The emission wavelength of the fluorochrome excited by the incident light must approximately match the excitation wavelength of the second fluorochrome.
If light at the second emission wavelength is detected, it implies that the two fluorochromes were physically within a few nanometres. Used as a technique to probe protein or cell interactions.
(25 Jun 1999)
chemical energy Energy liberated or absorbed by a chemical reaction, e.g., oxidation of carbon, or absorbed in the formation of a chemical compound.
(05 Mar 2000)
conservation of energy The principle that the total amount of energy in a closed system remains always the same, none being lost or created in any chemical or physical process or in the conversion of one kind of energy into another, within that system.
(05 Mar 2000)
conservation of energy resources Planned management, use, and preservation of energy resources.
(12 Dec 1998)
primary energy <radiobiology> Energy before conversion. For instance, the United States uses about 30,000 megajoules of electricity per capita per year, but electricity is generally obtained by converting other forms of energy (primarily chemical/heat) at an efficiency of around 30%, so the U.S. Consumes 90,000 megajoules of primary energy per capita for electrical use. (Total U.S. Primary energy consumption is 300,000 megajoules per capita.)
(09 Oct 1997)
Helmholtz energy Energy equivalent to the internal energy minus the entropy contribution (TS).
(05 Mar 2000)
protein-energy malnutrition The lack of sufficient energy or protein to meet the body's metabolic demands, as a result of either an inadequate dietary intake of protein, intake of poor quality dietary protein, increased demands due to disease, or increased nutrient losses.
(12 Dec 1998)
high energy bond <chemistry> Chemical bonds that release more than 25kJ/mol on hydrolysis: their importance is that the energy can be used to transfer the hydrolysed residue to another compound. The risk in using the term is that students may think the bond itself is different in some way, whereas it is the compound that matters. Hydrolysis of creatine phosphate yields 42.7kJ/mol, of phosphoenolpyruvate, 53.2, ATP to ADP, 30.5: the latter is important because it shows that energetically the hydrolysis of creatine phosphate will suffice to reconstitute ATP, hence the use of creatine phosphate in muscle.
(18 Nov 1997)
high energy compounds Classically, a group of phosphoric esters whose hydrolysis takes place with a standard free energy change of -5 to -15 kcal/mol (or, -20 to -63 kJ/mol) (in contrast to -1 to -4 kcal/mol or, -4 to -17 kJ/mol) for simple phosphoric esters like glucose-6-phosphate or alpha-glycerophosphates), thus being capable of driving energy-consuming reactions in living cells or reconstituted cell-free systems; adenosine 5'-triphosphate, with respect to the beta-and gamma-phosphates, is the best known and is regarded as the immediate energy source for most metabolic syntheses. The general types are acid anhydrides, phosphoric esters of enols, phosphamic acid (R-NH-PO3H2) derivatives, acyl thioesters (e.g., of coenzyme A), sulfonium compound's (R3-S+), and aminoacyl esters of ribosyl moieties.
See: high energy phosphates.
(05 Mar 2000)
high energy particle generating unit A machine capable of providing highly energised radiation for the purposes of radiotherapy treatment.
(16 Dec 1997)
high energy phosphate bond See: high energy phosphates.
(05 Mar 2000)
high energy phosphates Those phosphate's that, on hydrolysis, yield an unusually large amount of energy; e.g., nucleotide polyphosphates such as ATP, enol phosphate's such as phosphoenolpyruvate.
See: high energy compounds.
Synonym: energy-rich phosphates.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á